|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.2 GBX | +15.79% |
|
-27.87% | -62.71% |
| May. 16 | EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target | AN |
| May. 15 | Vertu Motors ups dividend as hails record revenue | AN |
ValiRx plc confirmed the permanent appointment of Dr. Cathy Tralau-Stewart as Chief Scientific Officer. Dr. Cathy Tralau-Stewart was appointed as Interim CSO for ValiRx in 2022 under a consultancy arrangement. the company now announced that Cathy has agreed to become CSO on a permanent basis, focusing on developing a risk-balanced, collaborative preclinical pipeline.
She will also actively support the Company strategically through membership of the Executive team and as a Board observer.
| 1st Jan change | Capi. | |
|---|---|---|
| -62.71% | 3.19M | |
| +9.42% | 114B | |
| +11.84% | 104B | |
| -14.15% | 22.41B | |
| -1.05% | 22.28B | |
| -5.29% | 19.07B | |
| -38.29% | 18B | |
| -4.16% | 17.89B | |
| +7.99% | 14.28B | |
| +36.24% | 12.55B |
VALIRX PLC 
